Recall of Burlington Medical Demi Half Aprons Due to Attenuation Degradation
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Burlington Medical, LLC is recalling 29 units of their Demi Half Aprons because of potential attenuation degradation over time, affecting products manufactured between January 16, 2025, and January 21, 2026.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 15, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Burlington Medical, LLC is recalling their Demi Half Aprons due to a potential for attenuation degradation over time, which decreases the product's lifespan.
Which Products Are Affected
The affected products are Burlington Medical Demi Half Aprons with model number R8DHALFR. All serial numbers manufactured with Xenolite 800 attenuation material from January 16, 2025, to January 21, 2026, are included. UDI-DI codes are: 00197513001485 (DHALF8-R8DHALFR-L), 00197513001478 (DHALF8-R8DHALFR-M), 00197513001461 (DHALF8-R8DHALFR-S), 00197513001492 (DHALF8-R8DHALFR-XL), and 00197513001607 (DHALFSET8-R8DHALFR-SET). A total of 29 units are affected, with distribution nationwide in the United States and internationally to countries including Canada, Australia, Bangladesh, Chile, Hong Kong, India, Mexico, Malaysia, Panama, Singapore, Thailand, Taiwan, Uruguay, and Vietnam. The official recall number is Z-1763-2026.
What You Should Do
Consumers should follow the initial firm notification, which was issued via letter, and contact Burlington Medical, LLC for further instructions regarding the recall.
Why This Matters
This recall highlights potential safety concerns with medical devices that could affect their effectiveness, impacting 29 units distributed worldwide and emphasizing the need for reliable protective equipment in healthcare settings.
Source
This recall information is from the FDA, recall number Z-1763-2026. For more details, visit the FDA website at https://www.fda.gov (attribution based on FDA records).
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,553 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 15, 2026.
Frequently Asked Questions
Common questions about this FDA recall.